Cell phones and glioma risk: a review of the evidence Courtney CorleMilan MakaleSantosh Kesari Topic Review 19 August 2011 Pages: 1 - 13
Gemcitabine induced myositis in patients with pancreatic cancer: case reports and topic review Elena PentsovaAnli LiuAdília Hormigo Topic Review 03 August 2011 Pages: 15 - 21
Prognostic value of novel biomarkers in astrocytic brain tumors: nuclear receptor co-regulators AIB1, TIF2, and PELP1 are associated with high tumor grade and worse patient prognosis Zinovia KefalopoulouVassiliki TzelepiGeorgia Sotiropoulou-Bonikou Laboratory Investigation - Human/Animal Tissue 07 July 2011 Pages: 23 - 31
MGMT expression and promoter methylation status may depend on the site of surgical sample collection within glioblastoma: a possible pitfall in stratification of patients? Alessandro Della PuppaLuca PersanoDomenico d’Avella Laboratory Investigation - Human/Animal Tissue 02 July 2011 Pages: 33 - 41
Elevated expression of macrophage migration inhibitory factor correlates with tumor recurrence and poor prognosis of patients with gliomas Xiao-bing WangXiao-ying TianZhi Li Laboratory Investigation - Human/Animal Tissue 03 July 2011 Pages: 43 - 51
The genotoxic effect of radiofrequency waves on mouse brain Emin KaracaBurak DurmazOzgur Cogulu Laboratory Investigation - Human/Animal Tissue 06 July 2011 Pages: 53 - 58
Norcantharidin impairs medulloblastoma growth by inhibition of Wnt/β-catenin signaling Flora CimminoMaria Nunzia ScoppettuoloMassimo Zollo Laboratory Investigation - Human/Animal Tissue 07 July 2011 Pages: 59 - 70
Expression analysis of stem cell-related genes reveal OCT4 as a predictor of poor clinical outcome in medulloblastoma Carolina Oliveira RodiniDaniela Emi SuzukiOswaldo Keith Okamoto Laboratory Investigation - Human/Animal Tissue 02 July 2011 Pages: 71 - 79
The toxicity of intrathecal bevacizumab in a rabbit model of leptomeningeal carcinomatosis Priscilla K. BrastianosHarry C. BrastianosStuart A. Grossman Laboratory Investigation - Human/Animal Tissue 26 July 2011 Pages: 81 - 88
Growth-inhibitory effect of neurotrophin-3-secreting adipose tissue-derived mesenchymal stem cells on the D283-MED human medulloblastoma cell line Young-Hoon KimSeung Hee ChoChae-Yong Kim Laboratory Investigation - Human/Animal Tissue 01 July 2011 Pages: 89 - 98
The nonsteroidal anti-inflammatory drug celecoxib suppresses the growth and induces apoptosis of human glioblastoma cells via the NF-κB pathway Gangadhara Reddy SareddyKhamushavalli GeevimanPhanithi Prakash Babu Laboratory Investigation - Human/Animal Tissue 17 August 2011 Pages: 99 - 109
Quantification of edema reduction using differential quantitative T2 (DQT2) relaxometry mapping in recurrent glioblastoma treated with bevacizumab Benjamin M. EllingsonTimothy F. CloughesyWhitney B. Pope Clinical Study – Patient Study 25 June 2011 Pages: 111 - 119
Safety of concurrent bevacizumab therapy and anticoagulation in glioma patients Andrew D. NordenJulia BartolomeoPatrick Y. Wen Clinical Study – Patient Study 26 June 2011 Pages: 121 - 125
Prolonged temozolomide for treatment of glioblastoma: preliminary clinical results and prognostic value of p53 overexpression Nadia MalkounCyrus ChargariNicolas Magné Clinical Study – Patient Study 02 July 2011 Pages: 127 - 133
p53 expression predicts dismal outcome for medulloblastoma patients with metastatic disease Marco GessiAndré O. von BuerenTorsten Pietsch CLINICAL STUDY – PATIENT STUDY 28 July 2011 Pages: 135 - 141
Prophylactic intrathecal chemotherapy in primary CNS lymphoma Monica Sierra del RioDamien RicardKhé Hoang-Xuan Clinical Study – Patient Study 08 July 2011 Pages: 143 - 146
Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery Mark R. GilbertJohn KuhnMichael Prados Clinical Study – Patient Study 08 July 2011 Pages: 147 - 153
Salvage treatment with temozolomide in refractory or relapsed primary central nervous system lymphoma and assessment of the MGMT status Keishi MakinoHideo NakamuraJun-ichi Kuratsu Clinical Study – Patient Study 01 July 2011 Pages: 155 - 160
Progression of the lung cancer primary correlates with the identification of new brain metastases after initial radiosurgery Jung Ho HanDong Gyu KimHee-Won Jung Clinical Study - Patient Study 06 July 2011 Pages: 161 - 167
Brain metastases from breast cancer: proposition of new prognostic score including molecular subtypes and treatment Romuald Le ScodanChristophe MassardEmmanuelle Mouret-Fourme Clinical Study – Patient Study 07 July 2011 Pages: 169 - 176
Modification of loco-regional microenvironment in brain tumors by spinal cord stimulation. Implications for radio-chemotherapy B. ClavoF. RobainaJ. L. Carreras Clinical Study - Patient Study 12 July 2011 Pages: 177 - 184
Chronic lymphocytic leukemia with central nervous system involvement: report of two cases with a comprehensive literature review Alan A. MoazzamJan DrappatzSantosh Kesari Case Report 17 July 2011 Pages: 185 - 200
Gangliocytoma of the medulla oblongata demonstrating high tracer uptake on positron emission tomography Ryuji AwaRyosuke HanayaKazunori Arita Letter to the Editor 06 July 2011 Pages: 201 - 202
Subcutaneous malignant melanoma of the scalp surgical flap after brain irradiation for anaplastic astrocytoma Carmelo Lucio SturialeGiovanni SabatinoGiulio Maira Letter to the Editor 01 July 2011 Pages: 203 - 207
Intravenous administration of temozolomide as a useful alternative over oral treatment with temozolomide capsules in patients with gliomas Kazuya MotomuraAtsushi NatsumeToshihiko Wakabayashi Letter to the Editor 03 July 2011 Pages: 209 - 211
A new tool for grade II glioma studies: plotting cumulative time with quality of life versus time to malignant transformation Emmanuel MandonnetHugues DuffauLuc Bauchet Letter to the Editor 09 July 2011 Pages: 213 - 215
